WARNER HOUSE INC

WARNER HOUSE INC formulated and distributes HAP CAPS (High Achievement Potential capsules), a nutritional supplement containing L-Glutamine, Vitamin A, Vitamin C, Vitamin B complex, zinc, copper, manganese, selenium, and Co-Q-10, designed to aid cellular defenses with antioxidants and treat metabolic abnormalities in children with Down syndrome. This supplement received FDA approval in 1986.

Developed and formulated HAP CAPS (High Achievement Potential capsules), a nutritional supplement containing L-Glutamine, Vitamin A, Vitamin C, Vitamin B complex, zinc, copper, manganese, selenium, and Co-Q-10, to aid cellular defenses with antioxidants. This supplement was designed as a treatment for metabolic abnormalities in children with Down syndrome and received FDA approval in 1986.

Scheduled and held Down Syndrome Clinics in 46 states, Mexico, Australia, Germany, England, and India, treating thousands of children with Down syndrome from 1986 until 2004. The organization provided a synergistic approach to treatment, combining metabolic treatment, thyroid stimulation, and early intervention programs, and operated as a center for the study and treatment of Trisomy disorder during this period.

Offers programs that provide education and support healthcare initiatives.

Provided medical direction for a mobile unit for the Special Olympics in Southern California from 1986 to 2004.

From 1986 until 2004, WARNER HOUSE INC scheduled and held Down Syndrome Clinics in 46 states, Mexico, Australia, Germany, England, and India, treating thousands of children with Down syndrome. These clinics provided a synergistic approach to treatment, combining metabolic treatment, thyroid stimulation, and early intervention programs.

Ran Down Syndrome clinics in 46 U.S. states and multiple countries (Mexico, Australia, Germany, England, India) from 1986 to 2004, providing a synergistic treatment approach that included metabolic supplementation, thyroid stimulation, and early intervention for thousands of children with Down syndrome. Also operated as a center for the study and treatment of Trisomy disorders during the same period.

Operated as a center for the study and treatment of Trisomy disorders from 1986 to 2004, conducting Down Syndrome Clinics in 46 U.S. states and multiple countries (Mexico, Australia, Germany, England, India), treating thousands of children using a synergistic approach that included metabolic treatment, thyroid stimulation, and early intervention.

Provided medical direction for a mobile unit serving the Special Olympics in Southern California from 1986 to 2004 and originated the "Any Boy Can (Handicapped) Program" at the La Habra Boys Club, a nationally recognized initiative supporting youth with disabilities.

Provided medical direction for a mobile unit serving the Special Olympics in Southern California from 1986 to 2004 and originated the "Any Boy Can (Handicapped) Program" at the La Habra Boys Club, which received national recognition.

Originated and served as founding director for the "Any Boy Can (Handicapped) Program" at the La Habra Boys Club, which received a National Recognition Award.

Conducted multiple research studies on the effects of HAP CAPS in individuals with Down syndrome, including open case studies, measurement of amyloid beta and P-tau levels, and observation of physical, cognitive, and immunological outcomes such as increased height/weight percentiles, normalized facial features, reduced infection rates, and improved biomarkers compared to untreated individuals.

Formulated and developed HAP CAPS, a metabolic supplement containing antioxidants and essential nutrients, after two years of research in affiliation with Dr. Turkel, aimed at treating metabolic abnormalities in children with Down syndrome.

Formulated and developed HAP CAPS (High Achievement Potential capsules), a metabolic supplement containing antioxidants and essential nutrients, after two years of research and collaboration with Dr. Turkel, leading to FDA approval in 1986 for use in children with Down syndrome.

Presented findings on nutritional and metabolic treatments for Down Syndrome and related conditions at national and international conferences, universities, and professional meetings across the U.S. and abroad between 1984 and 2000, reaching over 1,000 medical professionals at key events.

Presented findings on nutritional and metabolic approaches to Down syndrome and related conditions at numerous national and international conferences, academic institutions, and professional meetings between 1984 and 2000, including topics such as antioxidant therapy, metabolic treatment, and alternative medical approaches for Down syndrome, autism, and learning disabilities.

Founded and conducted research at the Desert Flower Downs Clinic from 1984 to 1986, laying the groundwork for subsequent metabolic treatment programs for Down syndrome.

Founded and conducted research at the Desert Flower Downs Clinic from 1984 to 1986, establishing a foundation for metabolic treatment approaches later applied in broader clinical settings.

Conducted various studies to assess the effects of HAP CAPS on individuals with Down Syndrome, including quantifying blood plasma amyloid beta and P-tau levels, observing increases in height and musculature, more normalized facial features, and improved cognition. Research also included noncomparative, open case studies on patients with Down Syndrome to assess the effects of the metabolic supplement and presented findings at numerous international conferences and symposiums.

Conducted longitudinal research on Down Syndrome patients taking HAP Caps, including noncomparative case studies and biomarker analysis, observing significant improvements in growth, facial morphology, infection rates, and reduced amyloid beta and P-tau levels compared to untreated individuals.

WARNER HOUSE INC conducts research on the effects of HAP CAPS on individuals with Down Syndrome, including studies to quantify blood plasma amyloid beta and P-tau levels, observe changes in height, musculature, and facial features, and assess the impact on cognition and incidence of infections. The research also investigates the need for additional thyroid medication in treated children.

Presented an overview of Dr. Warner's treatment method to over 1,000 medical attendees at a National Perinatal Association meeting in Washington, D.C.

WARNER HOUSE INC offers programs that provide education and support healthcare initiatives, including presenting Dr. Warner's treatment method to medical professionals at conferences.